Michael Sylvester, MD
Otolaryngic Allergy · Fayetteville, GANPI 1245767383
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Stryker at 36.0% of the total.
Across 69 payments — averaging $76.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Integra Lifesciences Corporation$2K
- Sanofi$713
- Neurent Medical Limited$276
- GSK$212
- Regeneron Healthcare Solutions, Inc.$158
- plus $387 from 9 others
What the payments were for
- Travel & lodging$2,83354%
- Food & beverage$2,41546%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 13 | $1,891 |
| Integra Lifesciences Corporation | 11 | $1,611 |
| Sanofi | 12 | $713 |
| Neurent Medical Limited | 2 | $276 |
| GSK | 12 | $212 |
| Regeneron Healthcare Solutions, Inc. | 6 | $158 |
| Inspire Medical Systems, Inc. | 2 | $97 |
| AstraZeneca | 2 | $94 |
| Amgen | 2 | $40 |
| Medtronic | 2 | $38 |
| Optinose US, Inc. | 1 | $29 |
| Aerin Medical Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$3,140
- SCOPIS ENT$1,405
- INTEGRA DERMAL REGENERATION TEMPLATE$1,047
- PRIMATRIX$1,047
- DUPIXENT$644
- Acclarent Aera$404
- Inspira Air$404
- RELIEVA SPINPLUS NAV$404
- TruDi Probe$404
- NEUROMARK System$256
- NEUROMARK Radiofrequency Console$256
- AUDION ET DILATION SYSTEM$170
How this compares
Too few otolaryngic allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide | 11 | $2,223 |
| Prednisolone Acetate | 15 | $753 |
| Ofloxacin | 16 | $550 |
| Azelastine Hcl | 19 | $418 |
| Ipratropium Bromide | 14 | $314 |
| Doxycycline Hyclate | 18 | $207 |
| Famotidine | 56 | $201 |
| Omeprazole | 24 | $145 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $79 |
| Tramadol Hcl | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Fayetteville
- Sarah WiseAtlanta$77K
- John DelgaudioAtlanta$49K
- David DillardAthens$9K
- David OliverSavannah$5K
- Thomas EdwardsDecatur$4K
- Daniel SpielmanAtlanta$4K
- Michael CallahanGainesville$3K
- Kody BolkAtlanta$2K
- Emily BarrowAtlanta$1K
- Anthony BotrosAtlanta$820
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.